Date:9/28/2010

nal Health Jeffrey R. Binder, President & CEO, Biomet, IncDouglas C. Bryant, President & CEO, Quidel CorporationDavid Cassak, Vice President, Content & Managing Director, Medical Devices, EBI E.V. Clarke, EVP, Supply Chain, Owens & Minor, Inc.Sam Chawla, Executive Director, UBS Investment BankTim Dugan, Managing Partner, Water Street Healthcare PartnersVincent A. Forlenza, President, BDAlex Gorsky, Worldwide Chairman Medical Device & Diagnostics Executive Committee, Johnson & JohnsonWilliam A. Hawkins, Chairman & CEO, Medtronic, Inc.Stephen P. MacMillan, President & CEO, Stryker CorporationJames V. Mazzo, President, Abbott Medical Optics Inc. Daniel Meron, Partner, Latham & Watkins, LLPMichael R. Minogue, Chairman, President & CEO, Abiomed, Inc.Michael A. Mussallem, Chairman & CEO, Edwards Lifesciences CorporationCaroll H. Neubauer, Chairman & CEO, B. Braun Medical Inc. Daniel P. O'Day, COO, Diagnostics Division & Member of the Corporate Executive Committee, RocheTimothy A. Pratt, EVP, CAO, General Counsel & Secretary, Boston Scientific CorporationTimothy M. Ring, Chairman & CEO, C. R. Bard, Inc.Mark J. Robinson, Partner, Centerview PartnersStephen J. Ubl, President & CEO, AdvaMedTo learn more about the AdvaMed 2010 program, visit www.AdvaMed2010.com

About AdvaMedAdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.

'/>"/>

SOURCE AdvaMed 2010; AdvaMed Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. AdvaMed Selects Prolifiq as Member of Business Solutions Program
2. AdvaMed Releases New Survey Results on DTC Campaigns
3. Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009
4. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
5. Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference
6. Food and Drug Administration Expert to Deliver Keynote Address
7. Speakers to Focus on Translating Regenerative Medicine Science
8. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
9. Encorium Group, Inc. Provides Update on Its Previously Announced Rights Offering
10. PharmAthene Completes Previously Announced Registered Direct Offering
11. Formation of Contract Parenteral Drug Development Services Company Announced